| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |

* From the Department of Anaesthesiology and Reanimatology, Tottori University Faculty of Medicine, Tottori, Yonago, and
the Department of Anaesthesia, Toyooka Hospital, Toyooka, Hyogo, Japan.
Address correspondence to: Dr. Renyu Liu, Department of Anaesthesia, University of Pennsylvania, 3400 Spruce Street, 7th Dulles, Philadelphia, Pennsylvania 19104-4283, USA. E-mail: liu{at}mail.med.upenn.edu
| Abstract |
|---|
|
|
|---|
Methods: To investigate whether or not potassium channels play a role in the effect of volatile anesthetic on pulmonary vessels, isolated and perfused rabbit lungs were divided into four groups (n = 7 each): a control group without treatment, a glibenclamide (Glib) group treated with adenosine triphosphate-sensitive K+ (KATP) channel inhibitor, a 4-aminopyridine (4-AP) group treated with voltage-sensitive K+ (KV) channel inhibitor, and an iberiotoxin (IbTX) group treated with high conductance calcium-activated K+ (KCa) channel inhibitor. After inhibitor administration and stabilization, two minimum alveolar concentration (MAC) of halothane, enflurane, isoflurane, or 1.8 MAC of sevoflurane were randomly administered for 15 min followed by eight minutes of fresh gas mixture after each agent inhalation.
Results: Isoflurane did not change pulmonary vascular tension in the control group but instead constricted the pulmonary vessels when KV channels were inhibited with 4-AP; constrictive effects of enflurane and halothane were observed on pulmonary vessels, and were enhanced by KV channel inhibition with 4-AP, but they were inhibited by KCa channel inhibition with IbTX; the dilation effect of sevoflurane was observed on pulmonary vessels but was not significantly affected by any of the K+ channel inhibitors.
Conclusion: Halothane, enflurane and isoflurane, but not sevoflurane, regulate pulmonary vascular tension through KV and/or KCa channels in isolated rabbit lungs.
| Introduction |
|---|
|
|
|---|
| Materials and methods |
|---|
|
|
|---|
Experimental protocol
Following commencement of perfusion and ten minutes for stabilization, the lungs were divided into four groups in random order (n = 7, each) according to the K+ channel subtype inhibitor added into the perfusate from the reservoir. In the control group, no channel inhibitor was added. In the glibenclamide (Glib) group, the perfusate contained 10 µM Glib, a highly selective KATP channel inhibitor. In the iberiotoxin (IbTX) group, the perfusate contained 45 nM of IbTX, a highly selective inhibitor of KCa channels. In the 4-aminopyridine (4-AP) group, the perfusate contained 1 mM of 4-AP, a KV channel inhibitor. Twenty minutes elapsed for stabilization after inhibitor administration, then two minimum alveolar concentrations (MAC) of halothane (2.8%), sevoflurane (7.4%), isoflurane (4.0%), or 1.8 MAC enflurane (5.3%) were randomly administered for 15 min. The lungs were ventilated without volatile agent for eight minutes to wash out the anesthetic after each agent inhalation and to allow the pulmonary vascular tension to return to the pre-inhalation value. Halothane, enflurane, isoflurane, or sevoflurane was administered using an agent specific vaporizer and monitored with an anesthetic gas monitor.
The pulmonary vascular resistance (PVR) was determined before and after each inhibitor or anesthetic administration. Total PVR (Rt), pulmonary arterial resistance (Ra) and pulmonary venous resistance (Rv) were determined as described previously.4
Data are presented as mean ± SD. Within-group differences were analyzed using one-way analysis of variance (ANOVA) with repeated measures (Statview 4.5, Abacus Concepts, Berkeley, CA, USA). Pre- and post-agent administration comparison was performed with a t test. Multiple samples at the same time intervals were analyzed using one-way ANOVA. The differences in resistance among groups for each volatile anesthetic were analyzed with post hoc comparisons. Scheffes test was used for post hoc comparisons. A P < 0.05 was considered significant.
| Results |
|---|
|
|
|---|
|
|
|
|
| Discussion |
|---|
|
|
|---|
The vasodilation of cerebral7 and mesenteric vessels8 induced by isoflurane and sevoflurane appears to be mediated via the activation of KATP channels. In the present study, however, the effect of volatile anesthetics on pulmonary vascular tension was not affected by KATP channel inhibition. It is therefore likely that volatile anesthetics did not affect basal vascular tension through KATP channels in the pulmonary vessels.
Although KV channels in mesenteric vessels are not affected by isoflurane,8 4-AP-sensitive KV channels are suppressed reversibly by clinically relevant concentrations of halothane and isoflurane in canine coronary arteries.9 The results of the present study suggest that halothane, enflurane and isoflurane may regulate pulmonary vascular tension through KV channels. Enflurane and halothane may inhibit KV channels or strengthen the inhibitory effect of channel inhibitors.
Volatile anesthetics affect KCa channels in aortic endothelial cells10 and small mesenteric arteries.8 Our results suggest that halothane may also have significant effects on KCa channels in pulmonary vessels. Since the constrictive effect of halothane on pulmonary vessels was attenuated by IbTX, it is likely that halothane may activate KCa channels, and consequently hyperpolarize the membrane potential of smooth muscle cells.
In summary, pulmonary vascular effects vary between volatile anesthetics. Halothane constricted pulmonary vessels, and the constrictive effect was potentiated by KV channel inhibition (4-AP), attenuated by KCa channel inhibition (IbTX), but not altered by KATP channel inhibition (Glib). Enflurane constricted pulmonary vessels, and the constrictive effect was potentiated by KV channel inhibition, but not changed by KCa or KATP channel inhibition. Isoflurane, neither a vasoconstrictor nor dilator, constricted pulmonary vessels when KV channels were inhibited with 4-AP. Sevoflurane dilated pulmonary vessels, and dilation was not influenced by any K+ channel subtype inhibitor in isolated rabbit lungs. The results suggest that halothane, enflurane, and isoflurane (but not sevoflurane) regulate pulmonary vascular tension through KV and/or KCa channels in isolated rabbit lungs.
| Acknowledgments |
|---|
| Footnotes |
|---|
Revision received November 29, 2002. Accepted for publication August 20, 2002.
| References |
|---|
|
|
|---|
2 Fox KM, Henderson JR, Kaski JC, et al. Antianginal and anti-ischaemic efficacy of tedisamil, a potassium channel blocker. Heart 2000; 83: 16771.
3 Pellegrino M, Pellegrini M, Bigini P, Scimemi A. Properties of Ca2+-activated K+ channels in erythrocytes from patients with myotonic muscular dystrophy. Muscle Nerve 1998; 21: 146572.[Medline]
4 Liu R, Ueda M, Okazaki N, Ishibe Y. Role of potassium channels in isoflurane- and sevoflurane-induced attenuation of hypoxic pulmonary vasoconstriction in isolated perfused rabbit lungs. Anesthesiology 2001; 95: 93946.[Medline]
5 Ishibe Y, Gui X, Uno H, Shiokawa Y, Umeda T, Suekane K. Effect of sevoflurane on hypoxic pulmonary vasoconstriction in the perfused rabbit lung. Anesthesiology 1993; 79: 134853.[Medline]
6 Yuan XJ, Wang J, Juhaszova M, Golovina VA, Rubin LJ. Molecular basis and function of voltage-gated K+ channels in pulmonary arterial smooth muscle cells. Am J Physiol 1998; 274: L62135.
7 Iida H, Ohata H, Iida M, Watanabe Y, Dohi S. Isoflurane and sevoflurane induce vasodilation of cerebral vessels via ATP-sensitive K+ channel activation. Anesthesiology 1998; 89: 95460.[Medline]
8 Kokita N, Stekiel TA, Yamazaki M, Bosnjak ZJ, Kampine JP, Stekiel WJ. Potassium channelmediated hyperpolarization of mesenteric vascular smooth muscle by isoflurane. Anesthesiology 1999; 90: 77988.[Medline]
9 Buljubasic N, Rusch NJ, Marijic J, Kampine JP, Bosnjak ZJ. Effects of halothane and isoflurane on calcium and potassium channel currents in canine coronary arterial cells. Anesthesiology 1992; 76: 9908.[Medline]
10 Simoneau C, Thuringer D, Cai S, Garneau L, Blaise G, Sauve R. Effects of halothane and isoflurane on bradykinin-evoked Ca2+ influx in bovine aortic endothelial cells. Anesthesiology 1996; 85: 36679.[Medline]
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |